Why Kimberly-Clark (KMB)Is On Support Trend With Coca-Cola (CCE), United Technologies (UTX), Medicinova (MNOV)

Healthcare products maker Kimberly-Clark Corp. (KMB) reported Monday a profit for the first quarter that edged up one percent from last year, primarily reflecting lower expenses and organic sales growth. Adjusted earnings per share topped analysts’ expectations, for the reason that quarterly sales missed their estimates The company also reaffirmed its adjusted earnings guidance for full-year 2014. “We offered a solid first quarter with first-class organic sales growth and cost savings.” Kimberly-Clark Corporation (KMB), Personal Products, is currently trading at $110.66, which boosted 0.48%. The stock is trading -1.42% below its 52-week high and 24.14% above its 52-week low. With 1029533 of its shares exchanged hands during the day and 0.62 relative volume ratio, market capitalization of Kimberly-Clark Corporation moved to $41695.58 million. The float was recorded 375.34 million compared to 376.79 million outstanding shares. KMB’s monthly performance is 0.44%. Experts rate it a ‘Moderate Sell’ stock.

Coca-Cola Enterprises, Inc. CCE) declared that its first-quarter net income soared to $115 million or $0.44 per share, from $61 million or $0.21 per share, previous year. Earnings per share were $0.46 on a comparable basis. On average, 12 analysts polled by Thomson Reuters probable the company to declare profit per share of $0.44 for the quarter. Coca-Cola Enterprises Inc. (CCE), Beverages – Soft Drinks company, collapsed -0.40% in last trading session and ended the day on $44.58. The stock is trading -6.69% below its 52-week high and 34.62% above its 52-week low. With 2215245 of its shares exchanged hands during the day and 0.98 relative volume ratio, market capitalization of Coca-Cola Enterprises Inc. moved to $11208.75 million. The float was recorded 232.04 million compared to 251.43 million outstanding shares. CCE’s monthly performance is -5.19%. Experts rate it a ‘Hold’ stock.

United Technologies Corp declared, effective July 7, a dividend of 59 cents per common share payable Sept. 10 to shareowners of record at the close of business Aug. 15. United Technologies Corp. (UTX), Aerospace/Defense Products & Services, is currently trading at $116.79, which slashed -0.05%. The stock is trading -2.83% below its 52-week high and 32.05% above its 52-week low. Market capitalization of United Technologies Corp. is worth nearly $107064.90 million. The stock is currently trading at a P/E multiple of 19.02x with 1.64x PEG Ratio. UTX showed -1.77% weekly performance. We recommend to ‘Buy’ the stock.

Shares of Chelsea Therapeutics International Ltd. (CHTP) were up extra than 146 percent in as soon as-hours trading on Tuesday later FDA panel’s positive vote on the company’s New Drug Application for Northera. The company is seeking approval of Northera for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure (Parkinson’s disease, multiple system atrophy and pure autonomic failure), dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy. The FDA panel has voted 16-1 to recommend approval of Northera, and the final decision of the FDA is slated for February 14, 2014. In a move that will expand its portfolio of advanced wound care products into the growing skin substitute market, Derma Sciences Inc. MediciNova Inc. (MNOV), Biotechnology company, dropped -2.50% in last trading session and ended the day on $1.95. The stock is trading -62.86% below its 52-week high and 17.47% above its 52-week low. MNOV’s return on investment is -15.70%. Company’s 9.10% shares are under accumulation by financial institutions compare to 2.50% by insiders. MNOV’s yearly performance is -20.08%. Investment experts consider it a ‘Strong Buy’ stock.

About

Andy Weld, CFA, is an editor and equity analyst for The Downtown Leader. If you have a great story idea for Andy Weld, you can write at [Andy.Weld@downtownleader.com ].

POST YOUR COMMENTS